SS

Sumit Sehgal

Director Director DIN 07487249
DIN 07487249 First appointment May 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2016
Shareholding value Locked Premium profile

About Sumit Sehgal

Data last updated:

Sumit Sehgal has 10 years in corporate governance. Formerly with 1 company, such as Genex Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07487249
Primary Designation Director
First Appointment 03 May 2016
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Genex Pharmaceutical Private Limited U33208HR2016PTC063916
Director03 May 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Genex Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sumit Sehgal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumit Sehgal

Sumit Sehgal has 10 years in corporate governance. Formerly with 1 company, such as Genex Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Sumit Sehgal is associated with 0 companies as a director.

Sumit Sehgal has expertise in General Business.

Sumit Sehgal has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available